Edition:
United States

Hologic Inc (HOLX.OQ)

HOLX.OQ on NASDAQ Stock Exchange Global Select Market

40.82USD
24 Feb 2017
Change (% chg)

$0.52 (+1.29%)
Prev Close
$40.30
Open
$40.34
Day's High
$40.83
Day's Low
$40.31
Volume
478,231
Avg. Vol
786,435
52-wk High
$41.23
52-wk Low
$32.64

HOLX.OQ

Chart for HOLX.OQ

About

Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women's health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays,... (more)

Overall

Beta: 1.10
Market Cap(Mil.): $11,400.87
Shares Outstanding(Mil.): 279.30
Dividend: --
Yield (%): --

Financials

  HOLX.OQ Industry Sector
P/E (TTM): 34.89 51.59 29.63
EPS (TTM): 1.17 -- --
ROI: 5.19 7.69 12.96
ROE: 15.12 11.60 14.11

BRIEF-Cynosure says Compensation Committee established $13 mln cash pool from making severance payments related to Hologic deal

* Cynosure - Compensation committee established $13 million cash pool from making severance payments for persons without employment agreements relating to Hologic deal Source: (http://bit.ly/2lL68PF) Further company coverage:

Feb 22 2017

BRIEF-FDA grants PMA approval for Hologic's Aptima hepatitis C Quant DX Assay

* FDA grants PMA approval for Hologic's Aptima hepatitis C Quant DX Assay Source text for Eikon: Further company coverage:

Feb 15 2017

BRIEF-Cynosure agrees to termination fee of $57.7 mln for Hologic deal

* Hologic - upon termination of deal under specified circumstances Cynosure has agreed to pay co termination fee of about $57.7 million Source text - http://bit.ly/2kuOElN Further company coverage:

Feb 14 2017

Hologic to buy Cynosure to expand into medical aesthetics

Hologic Inc said on Tuesday it would acquire medical aesthetics company Cynosure Inc for $1.65 billion as it looks to capitalize on an increase in medical procedures that are not traditionally reimbursed.

Feb 14 2017

UPDATE 3-Hologic to buy Cynosure to expand into medical aesthetics

* Cynosure shares up 28 pct; Hologic down 3.6 pct (Adds analyst comments, details)

Feb 14 2017

BRIEF-Hologic to acquire Cynosure for $1.65 bln

* Hologic to acquire Cynosure, leader in medical aesthetics systems and technologies, in all-cash tender offer that combines two complementary businesses

Feb 14 2017

Hologic to buy Cynosure for $1.65 bln

Feb 14 Hologic Inc said on Tuesday that it would acquire medical aesthetics company Cynosure Inc for $1.65 billion.

Feb 14 2017

BRIEF-Hologic launches next-generation Novasure advanced global endometrial ablation system for the treatment of abnormal uterine bleeding

* Hologic launches next-generation Novasure advanced global endometrial ablation system for the treatment of abnormal uterine bleeding Source text for Eikon: Further company coverage:

Feb 02 2017

BRIEF-Hologic reports Q1 GAAP EPS of $0.30

* Qtrly revenue of $734.4 million increased 5.6%, or 6.3% in constant currency terms

Feb 01 2017

BRIEF-Hologic Q1 non-gaap EPS $0.52

* Hologic announces financial results for first quarter of fiscal 2017

Feb 01 2017

More From Around the Web

Competitors

Earnings vs. Estimates